Skip to main content
. 2020 Jul 30;12:1758835920918499. doi: 10.1177/1758835920918499

Table 5.

Sensitivities and specificities for the PLS-DA classification of Raman spectra from lymphocytes of healthy donors and prostate cancer patients, as well as lymphocytes spectra from patients with different GS.

Patients Number of LVs Sensitivity Specificity
Healthy donors versus prostate cancer patients 07 92% 90%
GS 9 versus GS 8 03 65% 85%
GS 9 versus GS 7 10 85% 95%
GS 8 versus GS 7 13 80% 75%

GS, Gleason score; PLS-DA, partial least squares discriminant analysis.